Story · Medicine & Biotech
Aakash Desai: “Playing Chess With Cancer” in EGFRm NSCLC
1 outlet · first reported by OncoDaily on
Aakash Desai, Associate Professor at UAB O’Neal Cancer Center, shared on X: “My 2022 JAMA Oncology essay ‘Avoiding Checkmate’, seems relevant for thinking about EGFR lung cancer. Post-osimertinib EGFRm NSCLC: (OncoDaily)
Coverage, in order
-
Aakash Desai: “Playing Chess With Cancer” in EGFRm NSCLCAakash Desai, Associate Professor at UAB O’Neal Cancer Center, shared on X: “My 2022 JAMA Oncology essay ‘Avoiding Checkmate’, seems relevant for thinking about EGFR lung cancer. Post-osimertinib EGFRm NSCLC:
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.